Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a Prospective, Multicenter, Open-Label Randomized Controlled Trial
Artículo
Material complementario disponible
Artículo
DOAJ
Abstract
BackgroundTripterygium glycoside tablets (TGTs), a traditional Chinese medicine–based therapy and a type of conventional synthetic disease-modifying antirheumatic drug (csDMARD), have shown promise...
LCC LCC:Medicine; TENDOkNvbXB1dGVyIGFwcGxpY2F0aW9ucyB0byBtZWRpY2luZS4gTWVkaWNhbCBpbmZvcm1hdGljcw~~Idioma eng
Material complementario disponibleEl enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Material complementario